Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- INDUSTRY
- OSTI ID:
- 1095375
- Journal Information:
- ACS Med. Chem. Lett., Vol. 4, Issue (9) ; 09, 2013
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor
Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
Journal Article
·
Mon Aug 31 00:00:00 EDT 2020
· ACS Medicinal Chemistry Letters
·
OSTI ID:1095375
+21 more
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor
Journal Article
·
Sun Jun 17 00:00:00 EDT 2018
· Journal of Medicinal Chemistry
·
OSTI ID:1095375
+17 more
Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
Journal Article
·
Mon Dec 14 00:00:00 EST 2020
· J. Med. Chem.
·
OSTI ID:1095375
+20 more